CY1118722T1 - Υποκατεστημενο βητα-φαινυλ-αλφα-υδροξυ προπανοϊκο οξυ, μεθοδος συνθεσης και χρηση αυτου - Google Patents

Υποκατεστημενο βητα-φαινυλ-αλφα-υδροξυ προπανοϊκο οξυ, μεθοδος συνθεσης και χρηση αυτου

Info

Publication number
CY1118722T1
CY1118722T1 CY20171100327T CY171100327T CY1118722T1 CY 1118722 T1 CY1118722 T1 CY 1118722T1 CY 20171100327 T CY20171100327 T CY 20171100327T CY 171100327 T CY171100327 T CY 171100327T CY 1118722 T1 CY1118722 T1 CY 1118722T1
Authority
CY
Cyprus
Prior art keywords
finyl
alpha
composition
propanoic acid
hydroxy propanoic
Prior art date
Application number
CY20171100327T
Other languages
English (en)
Inventor
Xiaohui Zheng
Qunzheng Zhang
Shixiang Wang
Xinfeng Zhao
Original Assignee
Northwest University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Northwest University filed Critical Northwest University
Publication of CY1118722T1 publication Critical patent/CY1118722T1/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/612—Esters of carboxylic acids having a carboxyl group bound to an acyclic carbon atom and having a six-membered aromatic ring in the acid moiety
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/66—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
    • C07C69/73—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of unsaturated acids
    • C07C69/732—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of unsaturated acids of unsaturated hydroxy carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/45—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups
    • C07C233/46—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom
    • C07C233/48—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom having the carbon atom of the carboxamide group bound to an acyclic carbon atom of a saturated carbon skeleton containing rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
    • C07C235/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton
    • C07C235/32—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton containing six-membered aromatic rings
    • C07C235/34—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton containing six-membered aromatic rings having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/62—Halogen-containing esters
    • C07C69/65—Halogen-containing esters of unsaturated acids
    • C07C69/653—Acrylic acid esters; Methacrylic acid esters; Haloacrylic acid esters; Halomethacrylic acid esters
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/79—Acids; Esters
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/79—Acids; Esters
    • C07D213/80—Acids; Esters in position 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/44—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D317/46—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D317/48—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
    • C07D317/50—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to atoms of the carbocyclic ring
    • C07D317/60—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14—The ring being saturated
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00—Systems containing two condensed rings
    • C07C2602/36—Systems containing two condensed rings the rings having more than two atoms in common
    • C07C2602/42—Systems containing two condensed rings the rings having more than two atoms in common the bicyclo ring system containing seven carbon atoms

Abstract

Η παρούσα εφεύρεση αφορά σε μία ένωση του τύπου (I), όπου R1, R2 και R3 εκάστη ανεξαρτήτως επιλέγεται από Η, OH, F, CI, Br, μεθόξυ και αιθόξυ· ή εναλλακτικώς, R1 και R2 μαζί σχηματίζουν -OCH2O-, R3 επιλέγεται από Η, ΟΗ, μεθόξυ, αιθόξυ και αλογόνα· R4 είναι ΟΗ ή ακυλόξυ· R5 είναι κυκλοαλκοξύλ, άμινο και υποκατεστημένη άμινο, και όταν R5 επιλέγεται από άμινο, τουλάχιστον μία των R1, R2 και R3 δεν είναι Η. Η παρούσα εφεύρεση περαιτέρω αφορά σε μία μέθοδο για σύνθεση μιας ένωσης του τύπου (I), και χρήση της ένωσης του τύπου (I) στην βιομηχανική κατασκευή ενός φαρμάκου για την αποτροπή ή θεραπεία καρδιαγγειακών ή εγκεφαλοαγγειακών ασθενειών.
CY20171100327T 2006-05-15 2017-03-15 Υποκατεστημενο βητα-φαινυλ-αλφα-υδροξυ προπανοϊκο οξυ, μεθοδος συνθεσης και χρηση αυτου CY1118722T1 (el)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CNB2006100427873A CN100415709C (zh) 2006-05-15 2006-05-15 β-(3,4-二羟基苯基)-α-羟基丙酸冰片酯、其合成方法和用途
EP07721123A EP2019090B1 (en) 2006-05-15 2007-05-14 Substituted beta-phenyl-alpha-hydroxy propanoic acid, synthesis method and use thereof

Publications (1)

Publication Number Publication Date
CY1118722T1 true CY1118722T1 (el) 2017-07-12

Family

ID=37442796

Family Applications (2)

Application Number Title Priority Date Filing Date
CY20131100125T CY1113676T1 (el) 2006-05-15 2013-02-13 Υποκατεστημενο βητα-φαινυλο-αλφα-υδροξυ προπιονικο οξυ, μεθοδος συνθεσης και χρηση του
CY20171100327T CY1118722T1 (el) 2006-05-15 2017-03-15 Υποκατεστημενο βητα-φαινυλ-αλφα-υδροξυ προπανοϊκο οξυ, μεθοδος συνθεσης και χρηση αυτου

Family Applications Before (1)

Application Number Title Priority Date Filing Date
CY20131100125T CY1113676T1 (el) 2006-05-15 2013-02-13 Υποκατεστημενο βητα-φαινυλο-αλφα-υδροξυ προπιονικο οξυ, μεθοδος συνθεσης και χρηση του

Country Status (20)

Country Link
US (1) US8017786B2 (el)
EP (2) EP2514739B1 (el)
JP (1) JP5094845B2 (el)
KR (1) KR101059639B1 (el)
CN (1) CN100415709C (el)
AU (1) AU2007250364B8 (el)
BR (1) BRPI0712101B8 (el)
CA (1) CA2652299C (el)
CY (2) CY1113676T1 (el)
DK (2) DK2514739T3 (el)
ES (1) ES2618677T3 (el)
HU (1) HUE032505T2 (el)
IL (1) IL195313A (el)
MY (1) MY148134A (el)
NZ (1) NZ572958A (el)
PL (2) PL2514739T3 (el)
PT (1) PT2514739T (el)
RU (1) RU2421443C2 (el)
SI (2) SI2514739T1 (el)
WO (1) WO2007131446A1 (el)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100415709C (zh) 2006-05-15 2008-09-03 西北大学 β-(3,4-二羟基苯基)-α-羟基丙酸冰片酯、其合成方法和用途
CN101607897B (zh) * 2008-06-18 2012-10-24 复旦大学 (z)-2-乙酰氧基-3-(3,4-二羟基苯基)丙烯酸及其合成方法和用途
JP6196551B2 (ja) 2010-04-12 2017-09-13 スパーナス ファーマシューティカルズ インコーポレイテッド ビロキサジン塩を製造する方法及びその新規な多形
CN102030648B (zh) * 2010-12-07 2013-04-03 西北大学 3-(3,4-二羟基苯基)-2-羟基丙酸酯的不对称合成方法
CN102432468B (zh) * 2011-11-21 2014-03-26 中国人民解放军第四军医大学 丹参素冰片酯的不对称合成方法
WO2014091465A2 (en) * 2012-12-16 2014-06-19 Mahesh Kandula Compositions and methods for the treatment of metabolic syndrome and lipid disorders
CN103232347B (zh) * 2013-04-12 2015-09-16 合肥工业大学 一种cns药物的脑靶向前药及其制备方法以及冰片在cns药物脑靶向前药中的用途
CN103570547B (zh) * 2013-10-09 2016-04-20 西安石油大学 一种丹参素异丙酯的工业化合成方法
CN103570546B (zh) * 2013-10-09 2016-05-18 西安石油大学 一种丹参素冰片酯的工业化合成方法
CN105693817B (zh) 2014-11-27 2020-06-05 西北大学 一类三肽化合物及其制备方法与应用
CN106496897A (zh) * 2016-10-14 2017-03-15 无锡三帝特种高分子材料有限公司 一种聚酯镀铝膜
CN107619376A (zh) * 2017-11-09 2018-01-23 宁波职业技术学院 一种缬氨酸冰片酯及其制备方法和应用
CN109928959B (zh) * 2017-12-18 2020-11-06 中国科学院上海营养与健康研究所 抗心肌肥厚的药物、制备方法和用途
CN108047048B (zh) * 2017-12-30 2021-01-12 苏州沪云肿瘤研究中心股份有限公司 一种苯丙酸酯类化合物及其制备方法和应用
CN109608356B (zh) * 2018-12-14 2021-11-05 南京医科大学 一类丙二酸单酯酰化的氨基酸(+)2-崁醇酯的衍生物及其应用
JP6768868B2 (ja) * 2019-03-29 2020-10-14 健裕生技股▲分▼有限公司 心筋再生を促進させるための化合物、その調製方法及びこれらの使用
JP2020164528A (ja) * 2020-04-28 2020-10-08 健裕生技股▲分▼有限公司 心筋再生を促進させるための化合物、その調製方法、医薬組成物及びこれらの使用
CN114394901A (zh) * 2021-12-30 2022-04-26 广东医科大学附属第二医院 一种丹参素特戊酸甲酯衍生物及其制备方法
US11891353B1 (en) 2023-08-28 2024-02-06 King Faisal University 3,3′-(hydrazine-1,2-diyl)bis(1-(naphthalen-2-yloxy)propan-2-ol) as an ecofriendly insecticidal agent against Spodoptera littoralis (boisd.)

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60255774A (ja) * 1984-06-01 1985-12-17 Dai Ichi Seiyaku Co Ltd テトラヒドロナフタレン誘導体
RU2092169C1 (ru) 1992-08-20 1997-10-10 Раиса Павловна Свистунова Местное противовоспалительное средство "сальвинол"
JP3050733B2 (ja) * 1992-10-16 2000-06-12 中外製薬株式会社 ４−アルコキシ−２，６−ジ−ｔ−ブチルフェノール誘導体
US5736537A (en) * 1995-09-12 1998-04-07 Estee Lauder, Inc. Dehydroep:androsterone sailcylate useful against skin atrophy
WO1997015546A1 (fr) * 1995-10-26 1997-05-01 Nippon Shinyaku Co., Ltd. Derives d'acide carboxylique et compositions pharmaceutiques
CN1161140C (zh) * 2001-11-09 2004-08-11 天津天士力制药股份有限公司 一种预防和治疗冠心病心绞痛的药物及其制备方法和其它用途
WO2003002575A1 (en) * 2001-06-28 2003-01-09 Dr. Reddy's Laboratories Ltd. 3-ARYL-$G(a)-OXY SUBSTITUTED PROPANOIC ACIDS AND A PROCESS FOR THEIR PREPARATION
FR2842523A1 (fr) * 2002-07-17 2004-01-23 Sanofi Synthelabo Derives d'acylaminothiazole, leur preparation et leur application en therapeutique
CN100441563C (zh) * 2004-06-03 2008-12-10 西安交通大学 β-（3，4-二羟基苯基）-α-羟基丙酸异丙酯及其合成方法
CN100415709C (zh) 2006-05-15 2008-09-03 西北大学 β-(3,4-二羟基苯基)-α-羟基丙酸冰片酯、其合成方法和用途

Also Published As

Publication number Publication date
AU2007250364A1 (en) 2007-11-22
DK2514739T3 (en) 2017-04-03
SI2019090T1 (sl) 2013-02-28
RU2421443C2 (ru) 2011-06-20
KR20090013231A (ko) 2009-02-04
PL2514739T3 (pl) 2017-09-29
CN100415709C (zh) 2008-09-03
PT2514739T (pt) 2017-03-09
BRPI0712101B8 (pt) 2021-05-25
CN1868998A (zh) 2006-11-29
CA2652299A1 (en) 2007-11-22
DK2019090T3 (da) 2013-01-21
CA2652299C (en) 2011-12-20
JP5094845B2 (ja) 2012-12-12
EP2514739B1 (en) 2016-12-21
US20090131677A1 (en) 2009-05-21
EP2019090A4 (en) 2010-01-27
AU2007250364B8 (en) 2012-01-19
WO2007131446A1 (fr) 2007-11-22
CY1113676T1 (el) 2016-06-22
NZ572958A (en) 2011-11-25
EP2514739A1 (en) 2012-10-24
EP2019090A1 (en) 2009-01-28
IL195313A0 (en) 2009-08-03
HUE032505T2 (en) 2017-09-28
BRPI0712101A2 (pt) 2012-01-17
ES2618677T3 (es) 2017-06-21
RU2008145090A (ru) 2010-06-20
SI2514739T1 (sl) 2017-04-26
KR101059639B1 (ko) 2011-08-25
IL195313A (en) 2013-12-31
BRPI0712101B1 (pt) 2020-08-11
MY148134A (en) 2013-02-28
PL2019090T3 (pl) 2013-02-28
JP2009537462A (ja) 2009-10-29
EP2019090B1 (en) 2012-11-14
US8017786B2 (en) 2011-09-13
AU2007250364B2 (en) 2011-05-26

Similar Documents

Publication Publication Date Title
CY1118722T1 (el) Υποκατεστημενο βητα-φαινυλ-αλφα-υδροξυ προπανοϊκο οξυ, μεθοδος συνθεσης και χρηση αυτου
NO20073790L (no) Kjemiske forbindelser
NO20073788L (no) Kjemiske forbindelser
CY1121854T1 (el) Αρυλoαζoλ-2-υλ κυανοαιθυλαμινο ενωσεις, μεθοδος κατασκευης και μεθοδος χρησης αυτων
CY1120617T1 (el) 1,2,5-οξαδιαζολια ως αναστολεις 2,3-διοξυγενασης ινδολοαμινης
EA200700851A1 (ru) Получение и применение бифенил-4-илкарбониламинокислотных производных для лечения ожирения
BRPI0417543A (pt) quinolinas úteis no tratamento de doença cardiovascular
TW200716606A (en) Chemical compounds
TW200800963A (en) Chemical compounds
EA200801428A1 (ru) Производные пиридиазинона для лечения опухолей
EA200801362A1 (ru) Пиримидинил бензотиофеновые соединения
EA201100447A1 (ru) Органические соединения
CY1111702T1 (el) Τα παραγωγα ινδολης ως αγωνιστες υποδοχεων s1p1
ECSP099818A (es) Procesos para la preparacion de pirazoles
CY1113573T1 (el) Selurampanel
DK1809288T3 (da) Anvendelse af 1,4-bis-(3-aminoalkyl)piperazinderivater ved behandling af neurodegenerative sygdomme
EA201000895A1 (ru) Композиции и способы для лечения лизосомных болезней
ATE517873T1 (de) 6-oxo-1,6-dihydropyrimidin-2-yle bei der behandlung proliferativer krankheiten
CY1112670T1 (el) Παραγωγα του 5.6-bisaryl-2-πυριδιν-καρβοξαμιδιου, η παρασκευη τους και η εφαρμογη τους σε θεραπευτικη αγωγη ως ανταγωνιστες των υποδοχεων στην ουροτενσινη ii
EA201170344A1 (ru) Азаиндольные ингибиторы iap
EA200801425A1 (ru) Диазепиноны
EA200701584A1 (ru) Органические соединения, применяемые для лечения болезни альцгеймера, их применение и способ получения
MX2007008349A (es) Nueva sintesis de una etapa de aminas disustituidas utiles.
ATE431348T1 (de) Thiaepothilone zur behandlung von krebserkrankungen
CY1106649T1 (el) Νεα 1-μεθοξυ-2-φαινυλ-αιθενια χρησιμα δια την παρασκευην 5-καρβοξαλδεϋδο-2,3-διϋδροβενζοξεπινων